<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">sibmed</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский научный медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Сибирский научный медицинский журнал</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-2512</issn><issn pub-type="epub">2410-2520</issn><publisher><publisher-name>ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18699/SSMJ20220302</article-id><article-id custom-type="elpub" pub-id-type="custom">sibmed-800</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>Роль Helicobacter pylori в патогенезе некоторых гематологических заболеваний</article-title><trans-title-group xml:lang="en"><trans-title>Helicobacter pylori roles in haematology disease pathogenesis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9809-2294</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Потапова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Potapova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Марина Валериановна Потапова, к.м.н.</p><p>410012, г. Саратов, ул. Большая Казачья, 112</p></bio><bio xml:lang="en"><p>Marina V. Potapova, candidate of medical sciences</p><p>410012, Saratov, Bolshaya Kazachya str., 112</p></bio><email xlink:type="simple">marin9@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6276-5346</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брояка</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Broyaka</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нелли Александровна Брояка, к.м.н.</p><p>410012, г. Саратов, ул. Большая Казачья, 112</p></bio><bio xml:lang="en"><p>Nelli A. Broyaka, candidate of medical sciences</p><p>410012, Saratov, Bolshaya Kazachya str., 112</p></bio><email xlink:type="simple">n.a.broyaka@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2675-0291</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Скворцов</surname><given-names>К. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Skvortsov</surname><given-names>K. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Константин Юрьевич Скворцов, к.м.н.</p><p>410012, г. Саратов, ул. Верхний рынок, 10</p></bio><bio xml:lang="en"><p>Konstantin Yu. Skvortsov, candidate of medical sciences</p><p>410012, Saratov, Verkhniy Rynok, 10</p></bio><email xlink:type="simple">kyskvortsov@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0225-3429</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Конобеева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Konobeeva</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елена Владимировна Конобеева, к.м.н.</p><p>410012, г. Саратов, ул. Большая Казачья, 112</p></bio><bio xml:lang="en"><p>Elena V. Konobeeva, candidate of medical science</p><p>410012, Saratov, Bolshaya Kazachya str., 112</p></bio><email xlink:type="simple">tevla@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Саратовский государственный медицинский университет им. В.И. Разумовского Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saratov State Medical University n.a. V.I. Razumovsky of Minzdrav of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Саратовский медицинский университет «Реавиз»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saratov Medical University «Reaviz»</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>27</day><month>06</month><year>2022</year></pub-date><volume>42</volume><issue>3</issue><fpage>18</fpage><lpage>35</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Потапова М.В., Брояка Н.А., Скворцов К.Ю., Конобеева Е.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Потапова М.В., Брояка Н.А., Скворцов К.Ю., Конобеева Е.В.</copyright-holder><copyright-holder xml:lang="en">Potapova M.V., Broyaka N.A., Skvortsov K.Y., Konobeeva E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://sibmed.elpub.ru/jour/article/view/800">https://sibmed.elpub.ru/jour/article/view/800</self-uri><abstract><p>Helicobacter pylori считается одной из значимых причин формирования патологии желудочно-кишечного тракта. Данные о роли хеликобактериоза в развитии внежелудочных заболеваний подтверждаются положительным эффектом эрадикационной терапии, в частности, на нормализацию картины периферической крови. Несмотря на это, многие аспекты остаются нераскрытыми. Однако несомненно, что Н. pylori при своей персистенции на желудочном эпителии создает условия для хронизации местного и системного воспаления. Целью обзора явился анализ литературных данных о роли бактериальных факторов Н. pylori в развитии железо- и В12-дефицитной анемии, а также тромбоцитопенической пурпуры, включенных Международным консенсусом в круг показаний для диагностики и лечения хеликобактерной инфекции. Материал и методы. Поиск источников литературы осуществлен с помощью баз данных PubMed, CyberLeninka, eLibrary, Google Scholar. Результаты. Работами последних лет показано вовлечение многих факторов патогенности Н. pylori в развитие анемии и тромбоцитопенической пурпуры через формирование эрозивно-язвенных поражений слизистой оболочки, гипоацидности, хронического системного воспаления и аутоиммунного ответа. Данные о связи этих изменений с гематологическими синдромами, как и о самостоятельном влиянии эрадикации на нормализацию лабораторных показателей крови, противоречивы. Не находит подтверждения теория конкуренции Н. pylori как симбионта за усвоение железа хозяина. Заключение. Представляются необходимыми дальнейшие исследования по взаимосвязи Н. pylori и заболеваний крови. Перспективно изучение и применение диетологических подходов к сохранению целостности слизевого барьера и предотвращению бактериальной адгезии.</p></abstract><trans-abstract xml:lang="en"><p>Helicobacter pylori is considered to be one of the significant reasons of formation of gastroduodenal pathology. Data on the role of H. pylori in the development of extragastric diseases are confirmed by a positive effect of eradication on peripheral blood changes. In spite of this fact both aspects are still not revealed. However, undoubtedly that H. pylori persistence on gastric epithelium creates conditions for chronic local and systematic inflammation. The aim of the sur- vey was the analysis of literary data about bacterial factors in the development of iron-, vitamin B12-deficiency anaemia and thrombocytopenic purpura included by the international consensus into the circle of evedences for diagnosis and treatment of H. pylori. Material and methods. There was accomplished search of literature sources with the help of data bases PubMed, CyberLeninka, eLibrary, Google Scholar. The results of our analysis specify mechanisms of cer- tain blood diseases pathogenesis in association with H. pylori. Multiple roles of virulent strains of pathogen in anaemia and thrombocytopenic purpura include: development of erosive and ulcerative lesions of mucosa, hypoacidity, chron- ic inflammation and autoimmune response. Data about these changes in haematological syndromes and independent eradication effects on blood parameters normalisation, are controversial. Н. pylori host iron competition theory has not been found convincing confirmation. Conclusions. It is necessary to study more deeply the connection of H. pylori and haematological diseases. The dietary research and application to maintain the mucous integrity and bacterial adhesion prevention are perspective.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Н. pylori</kwd><kwd>факторы патогенности</kwd><kwd>гастродуоденальная патология</kwd><kwd>внежелудочная пато- логия</kwd><kwd>железодефицитная анемия</kwd><kwd>В12-дефицитная анемия</kwd><kwd>тромбоцитопеническая пурпура</kwd><kwd>хроническое воспаление.</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Н. pylori</kwd><kwd>factors of pathogenesis</kwd><kwd>gastroduodenal pathology</kwd><kwd>extragastric pathology</kwd><kwd>iron-deficiency anaemia</kwd><kwd>В12-deficiency anaemia</kwd><kwd>thrombocytopenic purpura</kwd><kwd>systemic inflammation.</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В.Т., Маев И.В., Лапина Т.Л., Шептулин А.А., Трухманов А.С., Баранская Е.К., Абдулхаков Р.А., Алексеева О.П., Алексеенко С.А., Дехнич Н.Н., … Цуканов В.В. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению инфекции Helicobacter pylori у взрослых. Рос. ж. гастроэнтерол., гепатол., колопроктол. 2018;28(1):55–70. doi: 10.22416/1382-4376-2018-28-1-55-70</mixed-citation><mixed-citation xml:lang="en">Ivashkin V.T., Mayev I.V., Lapina T.L., Sheptulin A.A., Trukhmanov A.S., Baranskaya E.K., Abdulkhakov R.A., Alekseyeva O.P., Alekseyenko S.A., Dekhnich N.N., … Tsukanov V.V. Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(1):55–70. [In Russian]. doi: 10.22416/1382-4376-2018-28-1-55-70</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнова О.В., Синяков А.А. Влияние Helicobacter pylori на особенности цитокиновой регуляции при хроническом атрофическом гастрите. Инфекц. и иммунитет. 2020;10(1):187–192. doi: 10.15789/2220-7619-IOH-1167</mixed-citation><mixed-citation xml:lang="en">Smirnova O.V., Sinyakov A.A. Influence of Helicobacter pylori on cytokine regulation in chronic atrophic gastritis. Infektsiya i immunitet = Russian Journal of Infection and Immunity. 2020;10(1):18–192. [In Russian]. doi: 10.15789/2220-7619-IOH-1167</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Öztekin M., Yılmaz B., Agagündüz D., Capasso R. Overview of Helicobacter pylori infection: clinical features, treatment and nutritional aspects. Diseases. 2021;9(4):66. doi: 10.3390/diseases9040066</mixed-citation><mixed-citation xml:lang="en">Öztekin M., Yılmaz B., Agagündüz D., Capasso R. Overview of Helicobacter pylori infection: clinical features, treatment and nutritional aspects. Diseases. 2021;9(4):66. doi: 10.3390/diseases9040066</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chmiela M., Gonciarz W. Molecular mimicry in Helicobacter pylori infections. World J. Gastroenterol. 2017;23(22):3964–3977. doi: 10.3748/wjg.v23. i22.3964</mixed-citation><mixed-citation xml:lang="en">Chmiela M., Gonciarz W. Molecular mimicry in Helicobacter pylori infections. World J. Gastroenterol. 2017;23(22):3964–3977. doi: 10.3748/wjg.v23. i22.3964</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Campuzano-Maya G. Hematologic manifestations of Helicobacter pylori infection. World J. Gastroenterol. 2014;20(36):12818–12838. doi: 10.3748/wjg. v20.i36.12818</mixed-citation><mixed-citation xml:lang="en">Campuzano-Maya G. Hematologic manifestations of Helicobacter pylori infection. World J. Gastroenterol. 2014;20(36):12818–12838. doi: 10.3748/wjg. v20.i36.12818</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mladenova I. Clinical relevance of Helicobacter pylori infection. J. Clin. Med. 2021;10:3473. doi: 10.3390/jcm10163473</mixed-citation><mixed-citation xml:lang="en">Mladenova I. Clinical relevance of Helicobacter pylori infection. J. Clin. Med. 2021;10:3473. doi: 10.3390/jcm10163473</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Malfertheiner P., Megraud F., O’Morain C.A., Gisbert J.P., Kuipers E.J., Axon A.T., Bazzoli F., Gasbarrini A., Atherton J., Graham D.Y., ... European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection – the Maastricht V/ Florence Consensus Report. Gut. 2017;66:6–30. doi: 10.1136/gutjnl-2016-312288</mixed-citation><mixed-citation xml:lang="en">Malfertheiner P., Megraud F., O’Morain C.A., Gisbert J.P., Kuipers E.J., Axon A.T., Bazzoli F., Gasbarrini A., Atherton J., Graham D.Y., ... European Helicobacter and Microbiota Study Group and Consensus panel. Management of Helicobacter pylori infection – the Maastricht V/ Florence Consensus Report. Gut. 2017;66:6–30. doi: 10.1136/gutjnl-2016-312288</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chey W.D., Leontiadis G.I., Howden C.W., Moss S.F. ACG Clinical Guideline: treatment of Helicobacter pylori infection. Am. J. Gastroenterol. 2017;112(2):212–239. doi: 10.1038/ajg.2016.563</mixed-citation><mixed-citation xml:lang="en">Chey W.D., Leontiadis G.I., Howden C.W., Moss S.F. ACG Clinical Guideline: treatment of Helicobacter pylori infection. Am. J. Gastroenterol. 2017;112(2):212–239. doi: 10.1038/ajg.2016.563</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Tsay F.W., Hsu P.I. H. pylori infection and extra-gastroduodenal diseases. J. Biomed. Sci. 2018;25(1):65. doi: 10.1186/s12929-018-0469-6</mixed-citation><mixed-citation xml:lang="en">Tsay F.W., Hsu P.I. H. pylori infection and extra-gastroduodenal diseases. J. Biomed. Sci. 2018;25(1):65. doi: 10.1186/s12929-018-0469-6</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tseng D.S., Li D., Cholleti S.M., Wei J.C., Jodesty Y., Pham H.V. Effect of Helicobacter pylori treatment on unexplained iron deficiency anemia. Perm. J. 2019;23:18–195. doi: 10.7812/TPP/18-195</mixed-citation><mixed-citation xml:lang="en">Tseng D.S., Li D., Cholleti S.M., Wei J.C., Jodesty Y., Pham H.V. Effect of Helicobacter pylori treatment on unexplained iron deficiency anemia. Perm. J. 2019;23:18–195. doi: 10.7812/TPP/18-195</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Stasi R., Sarpatwari A., Segal J.B., Osborn J., Evangelista M.L., Cooper N., Provan D., Newland A., Amadori S., Bussel J.B. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2009;113:1231–1240. doi: 10.1182/ blood-2008-07-167155</mixed-citation><mixed-citation xml:lang="en">Stasi R., Sarpatwari A., Segal J.B., Osborn J., Evangelista M.L., Cooper N., Provan D., Newland A., Amadori S., Bussel J.B. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood. 2009;113:1231–1240. doi: 10.1182/ blood-2008-07-167155</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Blecker U., Renders F., Lanciers S., Vandenplas Y. Syncopes leading to the diagnosis of a Helicobacter pylori positive chronic active haemorrhagic gastritis. Eur. J. Pediatr. 1991;150(8):560–561. doi: 10.1007/BF02072207</mixed-citation><mixed-citation xml:lang="en">Blecker U., Renders F., Lanciers S., Vandenplas Y. Syncopes leading to the diagnosis of a Helicobacter pylori positive chronic active haemorrhagic gastritis. Eur. J. Pediatr. 1991;150(8):560–561. doi: 10.1007/BF02072207</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez-Castro K.I., Franceschi M., Noto A., Miraglia C., Nouvenne A., Leandro G., Meschi T., de’ Angelis G.L., di Mario F. Clinical manifestations of chronic atrophic gastritis. Acta Biomed. 2018;89(8):88– 92. doi: 10.23750/abm.v89i8-S.7921</mixed-citation><mixed-citation xml:lang="en">Rodriguez-Castro K.I., Franceschi M., Noto A., Miraglia C., Nouvenne A., Leandro G., Meschi T., de’ Angelis G.L., di Mario F. Clinical manifestations of chronic atrophic gastritis. Acta Biomed. 2018;89(8):88– 92. doi: 10.23750/abm.v89i8-S.7921</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Emiralioglu N., Yenicesu I., Sari S., Egritas O., Poyraz A., Pasaoglu O.T., Celik B., Dalgic B. An insight into the relationships between prohepcidin, iron deficiency anemia, and interleukin-6 values in pediatric Helicobacter pylori gastritis. Eur. J. Pediatr. 2015;174(7):903–910. doi: 10.1007/s00431-014-2482-4</mixed-citation><mixed-citation xml:lang="en">Emiralioglu N., Yenicesu I., Sari S., Egritas O., Poyraz A., Pasaoglu O.T., Celik B., Dalgic B. An insight into the relationships between prohepcidin, iron deficiency anemia, and interleukin-6 values in pediatric Helicobacter pylori gastritis. Eur. J. Pediatr. 2015;174(7):903–910. doi: 10.1007/s00431-014-2482-4</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Haile K., Yemane T., Tesfaye G., Wolde D., Timerga A., Haile A. Anemia and its association with Helicobacter pylori infection among adult dyspeptic patients attending Wachemo University Nigist Eleni Mohammad Memorial Referral Hospital, Southwest Ethiopia: A cross-sectional study. PLoS One. 2021;16(1):e0245168. doi: 10.1371/journal. pone.0245168</mixed-citation><mixed-citation xml:lang="en">Haile K., Yemane T., Tesfaye G., Wolde D., Timerga A., Haile A. Anemia and its association with Helicobacter pylori infection among adult dyspeptic patients attending Wachemo University Nigist Eleni Mohammad Memorial Referral Hospital, Southwest Ethiopia: A cross-sectional study. PLoS One. 2021;16(1):e0245168. doi: 10.1371/journal. pone.0245168</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Xu M.Y., Cao B., Yuan B.S., Yin J., Liu L., Lu Q.B. Association of anaemia with Helicobacter pylori infection: a retrospective study. Scientific Reports. 2017;7:13434. doi: 10.1038/s41598-017-13955-3</mixed-citation><mixed-citation xml:lang="en">Xu M.Y., Cao B., Yuan B.S., Yin J., Liu L., Lu Q.B. Association of anaemia with Helicobacter pylori infection: a retrospective study. Scientific Reports. 2017;7:13434. doi: 10.1038/s41598-017-13955-3</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Hou B., Zhang M., Liu M., Dai W., Lin Y., Li Y., Gong M., Wang G. Association of active Helicobacter pylori infection and anemia in elderly males. BMC Infectious Diseases. 2019;19:228. doi: 10.1186/s12879019-3849-y</mixed-citation><mixed-citation xml:lang="en">Hou B., Zhang M., Liu M., Dai W., Lin Y., Li Y., Gong M., Wang G. Association of active Helicobacter pylori infection and anemia in elderly males. BMC Infectious Diseases. 2019;19:228. doi: 10.1186/s12879019-3849-y</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Franceschi F., Giupponi B., Ražuka-Ebela D. Helicobacter pylori and extragastric diseases. Helicobacter. 2018;23(1):e12520. doi: 10.1111/hel.12520</mixed-citation><mixed-citation xml:lang="en">Franceschi F., Giupponi B., Ražuka-Ebela D. Helicobacter pylori and extragastric diseases. Helicobacter. 2018;23(1):e12520. doi: 10.1111/hel.12520</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Hudak L., Jaraisy A., Haj S., Muhsen K. An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter. 2017;22(1). doi: 10.1111/ hel.12330</mixed-citation><mixed-citation xml:lang="en">Hudak L., Jaraisy A., Haj S., Muhsen K. An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia. Helicobacter. 2017;22(1). doi: 10.1111/ hel.12330</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Tan H.J., Goh K.L. Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review. J. Dig. Dis. 2012;13:342–349. doi: 10.1111/j.1751-2980.2012.00599.x</mixed-citation><mixed-citation xml:lang="en">Tan H.J., Goh K.L. Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review. J. Dig. Dis. 2012;13:342–349. doi: 10.1111/j.1751-2980.2012.00599.x</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S.Y. Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection. Korean J. Intern. Med. 2016;31:835–844. doi: 10.3904/ kjim.2016.166</mixed-citation><mixed-citation xml:lang="en">Lee S.Y. Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection. Korean J. Intern. Med. 2016;31:835–844. doi: 10.3904/ kjim.2016.166</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Афанасенкова Т.Е., Голованова Е.Д., Дубская Е.E. Хронический Helicobacter pylori-индуцированный гастрит с эрозивным поражением слизистой оболочки желудка у пожилых. Эксперим. и клин. гастроэнтерол. 2019;(10):33–38. doi:10.31146/1682-8658-ecg-170-10-33-38</mixed-citation><mixed-citation xml:lang="en">Afanasenkova T.E., Golovanova E.D., Dubskaya E.E. Chronic Helicobacter pylori induced gastritis with erosive lesions of the gastric mucosa in the elderly. Eksperimental’naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2019;(10):33–38. [In Russian]. doi:10.31146/1682-8658-ecg-170-10-33-38</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Betesh A.L., Santa Ana C.A., Cole J.A., Fordtran J.S. Is achlorhydria a cause of iron deficiency anemia? Am. J. Clin. Nutr. 2015;102:9–19. doi. org/10.3945/ajcn.114.097394</mixed-citation><mixed-citation xml:lang="en">Betesh A.L., Santa Ana C.A., Cole J.A., Fordtran J.S. Is achlorhydria a cause of iron deficiency anemia? Am. J. Clin. Nutr. 2015;102:9–19. doi. org/10.3945/ajcn.114.097394</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Gravina A.G., Zagari R.M., de Musis C., Romano L., Loguercio C., Romano M. Helicobacter pylori and extragastric diseases: A review. World J. Gastroenterol. 2018;24(29):3204–3221. doi. org/10.3748/wjg. v24. i29.3204</mixed-citation><mixed-citation xml:lang="en">Gravina A.G., Zagari R.M., de Musis C., Romano L., Loguercio C., Romano M. Helicobacter pylori and extragastric diseases: A review. World J. Gastroenterol. 2018;24(29):3204–3221. doi. org/10.3748/wjg. v24. i29.3204</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Boyanova L. Role of Helicobacter pylori virulence factors for iron acquisition from gastric epithelial cells of the host and impact on bacterial colonization. Future Microbiol. 2011;6(8):843–846. doi: 10.2217/ fmb.11.75</mixed-citation><mixed-citation xml:lang="en">Boyanova L. Role of Helicobacter pylori virulence factors for iron acquisition from gastric epithelial cells of the host and impact on bacterial colonization. Future Microbiol. 2011;6(8):843–846. doi: 10.2217/ fmb.11.75</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Šterbenc A., Jarc E., Poljak M., Homan M. Helicobacter pylori virulence genes. World J. Gastroenterol. 2019;25(33):4870–4884. doi: 10.3748/wjg.v25. i33.4870</mixed-citation><mixed-citation xml:lang="en">Šterbenc A., Jarc E., Poljak M., Homan M. Helicobacter pylori virulence genes. World J. Gastroenterol. 2019;25(33):4870–4884. doi: 10.3748/wjg.v25. i33.4870</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Scott C., Arora G., Dickson K., Lehmann C. Iron chelation in local infection. Molecules. 2021;26:189. doi.org/10.3390/ molecules26010189</mixed-citation><mixed-citation xml:lang="en">Scott C., Arora G., Dickson K., Lehmann C. Iron chelation in local infection. Molecules. 2021;26:189. doi.org/10.3390/ molecules26010189</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Toyokuni S., Yanatori I., Kong Y., Zheng H., Motooka Y., Jiang L. Ferroptosis at the crossroads of infection, aging and cancer. Cancer Science. 2020;111:2665–2671. doi: 10.1111/cas.14496</mixed-citation><mixed-citation xml:lang="en">Toyokuni S., Yanatori I., Kong Y., Zheng H., Motooka Y., Jiang L. Ferroptosis at the crossroads of infection, aging and cancer. Cancer Science. 2020;111:2665–2671. doi: 10.1111/cas.14496</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Hamedi A.D., Farivar T.N., Rahmani B., Hajmanoochehri F., Razavi A.N., Jahanbin B., Dodaran M.S., Peymani A. The role of transferrin receptor in the Helicobacter pylori pathogenesis; L-ferritin as a novel marker for intestinal metaplasia. Microb. Pathog. 2019;126:157–164. doi: 10.1016/j.micpath.2018.10.039</mixed-citation><mixed-citation xml:lang="en">Hamedi A.D., Farivar T.N., Rahmani B., Hajmanoochehri F., Razavi A.N., Jahanbin B., Dodaran M.S., Peymani A. The role of transferrin receptor in the Helicobacter pylori pathogenesis; L-ferritin as a novel marker for intestinal metaplasia. Microb. Pathog. 2019;126:157–164. doi: 10.1016/j.micpath.2018.10.039</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Chmiela M., Kupcinskas J. Review: Pathogenesis of Helicobacter pylori infection. Helicobacter. 2019;24(1):e12638. doi: 10.1111/hel.12638</mixed-citation><mixed-citation xml:lang="en">Chmiela M., Kupcinskas J. Review: Pathogenesis of Helicobacter pylori infection. Helicobacter. 2019;24(1):e12638. doi: 10.1111/hel.12638</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Worst D.J., Otto B.R., de Graaff J. Iron-repressible outer membrane proteins of Helicobacter pylori involved in heme uptake. Infect. Immun. 1995;63(10):4161–4165. doi: 10.1128/iai.63.10.41614165.1995</mixed-citation><mixed-citation xml:lang="en">Worst D.J., Otto B.R., de Graaff J. Iron-repressible outer membrane proteins of Helicobacter pylori involved in heme uptake. Infect. Immun. 1995;63(10):4161–4165. doi: 10.1128/iai.63.10.41614165.1995</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Исаева Г.Ш., Валиева Р.И. Биологические свойства и вирулентность Helicobacter pylori. Клин. микробиол. и антимикроб. химиотерапия. 2018;20(1):14–23. doi:10.36488/cmac.2018.1.14-23</mixed-citation><mixed-citation xml:lang="en">Isaeva G.Sh., Valieva R.I. Biological characteristics and virulence of Helicobacter pylori. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya = Clinical Microbiology and Antimicrobial Chemotherapy. 2018;20(1):14–23. [In Russian]. doi:10.36488/ cmac.2018.1.14-23</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Olvera-Rosales L.B., Cruz-Guerrero A.E., Ramírez-Moreno E., Quintero-Lira A., ContrerasLópez E., Jaimez-Ordaz J., Castañeda-Ovando A., Añorve-Morga J., Calderón-Ramos Z.-G., Arias-Rico J. Impact of the gut microbiota balance on the health-disease relationship: the importance of consuming probiotics and prebiotics. Foods. 2021;10:1261. doi: 10.3390/ foods10061261</mixed-citation><mixed-citation xml:lang="en">Olvera-Rosales L.B., Cruz-Guerrero A.E., Ramírez-Moreno E., Quintero-Lira A., ContrerasLópez E., Jaimez-Ordaz J., Castañeda-Ovando A., Añorve-Morga J., Calderón-Ramos Z.-G., Arias-Rico J. Impact of the gut microbiota balance on the health-disease relationship: the importance of consuming probiotics and prebiotics. Foods. 2021;10:1261. doi: 10.3390/ foods10061261</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Yang J., Zhou X., Liu X., Ling Z., Ji F. Role of the gastric microbiome in gastric cancer: from carcinogenesis to treatment. Front. Microbiol. 2021;12:641322. doi: 10.3389/fmicb.2021.641322</mixed-citation><mixed-citation xml:lang="en">Yang J., Zhou X., Liu X., Ling Z., Ji F. Role of the gastric microbiome in gastric cancer: from carcinogenesis to treatment. Front. Microbiol. 2021;12:641322. doi: 10.3389/fmicb.2021.641322</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Muhsen K., Cohen D. Helicobacter pylori infection and iron stores: a systemic review and metaanalysis. Helicobacter. 2008;13:323–340. doi:10.1111/ j.1523-5378.2008.00617.x</mixed-citation><mixed-citation xml:lang="en">Muhsen K., Cohen D. Helicobacter pylori infection and iron stores: a systemic review and metaanalysis. Helicobacter. 2008;13:323–340. doi:10.1111/ j.1523-5378.2008.00617.x</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Andrews S.C., Robinson A.K., RodriguezQuinones F. Bacterial iron homeostasis. FEMS Microbio-logy Rev. 2003;27:215–237. doi: 10.1016/S01686445(03)00055-X</mixed-citation><mixed-citation xml:lang="en">Andrews S.C., Robinson A.K., RodriguezQuinones F. Bacterial iron homeostasis. FEMS Microbio-logy Rev. 2003;27:215–237. doi: 10.1016/S01686445(03)00055-X</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Briana R., Wilson L., Bogdan A.R., Miyazawa M., Hashimoto K., Tsuji Y. Siderophores in iron metabolism: from mechanism to therapy potential. Trends Mol. Med. 2016;22(12):1077–1090. doi:10.1016/j.molmed.2016.10.005</mixed-citation><mixed-citation xml:lang="en">Briana R., Wilson L., Bogdan A.R., Miyazawa M., Hashimoto K., Tsuji Y. Siderophores in iron metabolism: from mechanism to therapy potential. Trends Mol. Med. 2016;22(12):1077–1090. doi:10.1016/j.molmed.2016.10.005</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Kramer J., Özkaya Ö., Kümmerli R. Bacterial siderophores in community and host interactions. Nat. Rev. Microbiol. 2020;18(3):152–163. doi: 10.1038/ s41579-019-0284-4</mixed-citation><mixed-citation xml:lang="en">Kramer J., Özkaya Ö., Kümmerli R. Bacterial siderophores in community and host interactions. Nat. Rev. Microbiol. 2020;18(3):152–163. doi: 10.1038/ s41579-019-0284-4</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Поздеев О.К., Поздеева А.О., Валеева Ю.В., Гуляев П.Е., Савинова А.Н. Механизмы взаимодействия Hеlicobacter pylori с эпителием слизистой оболочки желудка. I. Факторы патогенности, способствующие успешной колонизации. Инфекц. и иммунитет. 2018;8(3):273– 283. doi:10.15789/2220-7619-2019-2-253-261</mixed-citation><mixed-citation xml:lang="en">Pozdeev O.K., Pozdeeva A.O., Valeeva Yu.V., Gulyaev P.E., Savinova A.N. Mechanisms of interaction of Helicobacter pylori with epithelium of gastric mucosa. I. Pathogenic factors promoting successful colonization. Infektsiya i immunitet = Russian Journal of Infection and Immunity. 2018;8(3):273–283. [In Russian]. doi:10.15789/2220-7619-2018-3-273-283</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Johnstonea T.C., Nolan E.M. Beyond iron: nonclassical biological functions of bacterial siderophores. Dalton Trans. 2015;44(14):6320–6339. doi:10.1039/c4dt03559c</mixed-citation><mixed-citation xml:lang="en">Johnstonea T.C., Nolan E.M. Beyond iron: nonclassical biological functions of bacterial siderophores. Dalton Trans. 2015;44(14):6320–6339. doi:10.1039/c4dt03559c</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Qi B., Han M. Microbial siderophore enterobactin promotes mitochondrial iron uptake and development of the host via interaction with ATP synthase. Cell. 2018;175(2):571–582. doi: 10.1016/j.cell.2018.07.032</mixed-citation><mixed-citation xml:lang="en">Qi B., Han M. Microbial siderophore enterobactin promotes mitochondrial iron uptake and development of the host via interaction with ATP synthase. Cell. 2018;175(2):571–582. doi: 10.1016/j.cell.2018.07.032</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Yokota S., Toita N., Yamamoto S., Fujii N., Konno M. Positive relationship between a polymorphism in Helicobacter pylori neutrophil-activating protein a gene and iron-deficiency anemia. Helicobacter. 2013;18:112–116. doi:10.1111/hel.12011</mixed-citation><mixed-citation xml:lang="en">Yokota S., Toita N., Yamamoto S., Fujii N., Konno M. Positive relationship between a polymorphism in Helicobacter pylori neutrophil-activating protein a gene and iron-deficiency anemia. Helicobacter. 2013;18:112–116. doi:10.1111/hel.12011</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Pich O.Q., Merrell D.S. The ferric uptake regulator of Helicobacter pylori: a critical player in the battle for iron and colonization of the stomach. Future Microbiol. 2013;8(6):725–738. doi: 10.2217/fmb.13.43</mixed-citation><mixed-citation xml:lang="en">Pich O.Q., Merrell D.S. The ferric uptake regulator of Helicobacter pylori: a critical player in the battle for iron and colonization of the stomach. Future Microbiol. 2013;8(6):725–738. doi: 10.2217/fmb.13.43</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Flores S.E., Aitchison A., Day A.S., Keenan J.I. Helicobacter pylori infection perturbs iron homeostasis in gastric epithelial cells. PLoS One. 2017;12(9):e0184026. doi: 10.1371/journal. pone.0184026</mixed-citation><mixed-citation xml:lang="en">Flores S.E., Aitchison A., Day A.S., Keenan J.I. Helicobacter pylori infection perturbs iron homeostasis in gastric epithelial cells. PLoS One. 2017;12(9):e0184026. doi: 10.1371/journal. pone.0184026</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Ellermann M., Arthur J.C. Siderophore-mediated iron acquisition and modulation of host-bacterial interactions. Free Radic. Biol. Med. 2017;105:68–78. doi: 10.1016/j.freeradbiomed.2016.10.489</mixed-citation><mixed-citation xml:lang="en">Ellermann M., Arthur J.C. Siderophore-mediated iron acquisition and modulation of host-bacterial interactions. Free Radic. Biol. Med. 2017;105:68–78. doi: 10.1016/j.freeradbiomed.2016.10.489</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Nairz M., Weiss G. Iron in infection and immunity. Mol. Aspects Med. 2020;75:100864. doi: 10.1016/j. mam.2020.100864</mixed-citation><mixed-citation xml:lang="en">Nairz M., Weiss G. Iron in infection and immunity. Mol. Aspects Med. 2020;75:100864. doi: 10.1016/j. mam.2020.100864</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss G., Ganz T., Goodnough L.T. Anemia of inflammation. Blood. 2019;33(1): 40–50. doi:10.1182/ blood-2018-06-856500</mixed-citation><mixed-citation xml:lang="en">Weiss G., Ganz T., Goodnough L.T. Anemia of inflammation. Blood. 2019;33(1): 40–50. doi:10.1182/ blood-2018-06-856500</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Pasini E., Corsetti G., Romano C., Aquilani R., Scarabelli T., Chen-Scarabelli C., Dioguardi F.S. Management of anaemia of chronic disease: beyond irononly supplementation. Nutrients. 2021;13:237. doi: 10.3390/nu 13010237</mixed-citation><mixed-citation xml:lang="en">Pasini E., Corsetti G., Romano C., Aquilani R., Scarabelli T., Chen-Scarabelli C., Dioguardi F.S. Management of anaemia of chronic disease: beyond irononly supplementation. Nutrients. 2021;13:237. doi: 10.3390/nu 13010237</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Madu A.J., Ughasoro M.D. Anaemia of chronic disease: an in-depth review. Med. Princ. Pract. 2017;26:1–9. doi: 10.1159/000452104</mixed-citation><mixed-citation xml:lang="en">Madu A.J., Ughasoro M.D. Anaemia of chronic disease: an in-depth review. Med. Princ. Pract. 2017;26:1–9. doi: 10.1159/000452104</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Jeyamani L., Jayarajan J., Leelakrishnan V., Swaminathan M. CagA and VacA genes of Helicobacter pylori and their clinical relevance. Indian J. Pathol. Microbiol. 2018;61(1):66–69. doi: 10.4103/IJPM. IJPM_234_17</mixed-citation><mixed-citation xml:lang="en">Jeyamani L., Jayarajan J., Leelakrishnan V., Swaminathan M. CagA and VacA genes of Helicobacter pylori and their clinical relevance. Indian J. Pathol. Microbiol. 2018;61(1):66–69. doi: 10.4103/IJPM. IJPM_234_17</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Yang J.Y., Kim P., Jeong S.-H., Lee S.W., Myung Y.S., Baeg M.K., Kim J.B. The effects of sulglycotide on the adhesion and the inflammation of Helicobacter pylori. Int. J. Environ. Res. Public Health. 2020;17:2918. doi:10.3390/ijerph17082918</mixed-citation><mixed-citation xml:lang="en">Yang J.Y., Kim P., Jeong S.-H., Lee S.W., Myung Y.S., Baeg M.K., Kim J.B. The effects of sulglycotide on the adhesion and the inflammation of Helicobacter pylori. Int. J. Environ. Res. Public Health. 2020;17:2918. doi:10.3390/ijerph17082918</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Hessey S.J., Spencer J., Wyatt J.I., Sobata G., Rathbone B.J., Axon A.T., Dixon M.F. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut. 1990;31:134–138. doi: 10.1136/gut.31.2.134</mixed-citation><mixed-citation xml:lang="en">Hessey S.J., Spencer J., Wyatt J.I., Sobata G., Rathbone B.J., Axon A.T., Dixon M.F. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut. 1990;31:134–138. doi: 10.1136/gut.31.2.134</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Guruge J.L., Falk P.G., Lorenz R.G., Dans M., Wirth H.P., Blaser M.J., Berg D.E., Gordon J.I. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc. Nat. Acad. Sci. USA. 1998;95(7):3925–3930. doi: 10.1073/pnas.95.7.3925</mixed-citation><mixed-citation xml:lang="en">Guruge J.L., Falk P.G., Lorenz R.G., Dans M., Wirth H.P., Blaser M.J., Berg D.E., Gordon J.I. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc. Nat. Acad. Sci. USA. 1998;95(7):3925–3930. doi: 10.1073/pnas.95.7.3925</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuo Y., Kido Y., Yamaoka Y. Helicobacter pylori outer membrane protein-related pathogenesis. Toxins (Basel). 2017;9:101. doi:10.3390/toxins9030101</mixed-citation><mixed-citation xml:lang="en">Matsuo Y., Kido Y., Yamaoka Y. Helicobacter pylori outer membrane protein-related pathogenesis. Toxins (Basel). 2017;9:101. doi:10.3390/toxins9030101</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Kato S., Osaki T., Kamiya S., Zhang X.S., Blaser M.J. Helicobacter pylori sabA gene is associated with iron deficiency anemia in childhood and adolescence. PLoS One. 2017;12:e0184046. doi:10.1371/journal.pone.0184046</mixed-citation><mixed-citation xml:lang="en">Kato S., Osaki T., Kamiya S., Zhang X.S., Blaser M.J. Helicobacter pylori sabA gene is associated with iron deficiency anemia in childhood and adolescence. PLoS One. 2017;12:e0184046. doi:10.1371/journal.pone.0184046</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Andersen L.P. Colonization and infection by Helicobacter pylori in humans. Helicobacter. 2007;12(2):12–15. doi: 10.1111/j.15235378.2007.00574.x</mixed-citation><mixed-citation xml:lang="en">Andersen L.P. Colonization and infection by Helicobacter pylori in humans. Helicobacter. 2007;12(2):12–15. doi: 10.1111/j.15235378.2007.00574.x</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Cover T.L. Helicobacter pylori diversity and gastric cancer risk. mBio. 2016;7(1):e01869-15. doi: 10.1128/mBio.01869-15</mixed-citation><mixed-citation xml:lang="en">Cover T.L. Helicobacter pylori diversity and gastric cancer risk. mBio. 2016;7(1):e01869-15. doi: 10.1128/mBio.01869-15</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Щербаков И.Т., Леонтьева Н.И., Филиппов В.С., Грачева Н.М., Соловьева А.И., Виноградов Н.А. Морфология воспаления слизистой оболочки желудка и двенадцатиперстной кишки с контаминацией Helicobacter pylori. Морфол. ведомости. 2019;27(3):39–45. doi: 10.20340/mvmn.19(27).03.39-45</mixed-citation><mixed-citation xml:lang="en">Shcherbakov I.T., Leont’ieva N.I., Filippov V.S., Grachyova N.M., Solov’yova A.I., Vinogradov N.A. The morphology of the inflammation of the gastric and duodenal mucosa with Helicobacter pylori contamination. Morfologicheskie vedomosti = Morphological Newsletter. 2019;27(3):39–45. https://doi. org/10.20340/mv-mn.19(27).03.39-45</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Пегашева И.Л., Павлович И.М., Гордиенко А.В., Чирский В.С., Ерохина А.А., Сварваль А.В. Влияние факторов патогенности Helicobacter pylori (Cag A и Vac A) на предраковые изменения слизистой оболочки желудка у больных хроническим гастритом. Эксперим. и клин. гастроэнтерол. 2019;(5):67–71. doi: 10.31146/1682-8658-ecg-165-567-71</mixed-citation><mixed-citation xml:lang="en">Pegasheva I.L., Pavlovich I.M., Gordienko A.V., Chyrskiy V.S., Erokhina A.A., Swarwal A.V. Influence of pathogenicity factors of Helicobacter pylori (Cag A and Vac A) on precancerous changes of gastric mucosa in patients with chronic gastritis. Eksperimental’naya i klinicheskaya gastroenterologiya = Experimental and Clinical Gastroenterology. 2019;(5):67–71. [In Russian]. doi: 10.31146/1682-8658-ecg-165-5-67-71</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Vernigorodskiy S.V., Sukhan D.S. The role of the CagA gene in the occurrence of the inflammatory response of the gastric mucosa in patients with chronic Helicobacter pylori-associated gastritis. Reports of Morphology. 2018;24(3):11–18. doi: 10.31393/morphology-journal-2018-24(3)-02</mixed-citation><mixed-citation xml:lang="en">Vernigorodskiy S.V., Sukhan D.S. The role of the CagA gene in the occurrence of the inflammatory response of the gastric mucosa in patients with chronic Helicobacter pylori-associated gastritis. Reports of Morphology. 2018;24(3):11–18. doi: 10.31393/morphology-journal-2018-24(3)-02</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Lahner E., Carabotti M., Annibale B. Treatment of Helicobacter pylori infection in atrophic gastritis. World J. Gastroenterol. 2018;24(22):2373–2380. doi: 10.3748/wjg.v24.i22.2373</mixed-citation><mixed-citation xml:lang="en">Lahner E., Carabotti M., Annibale B. Treatment of Helicobacter pylori infection in atrophic gastritis. World J. Gastroenterol. 2018;24(22):2373–2380. doi: 10.3748/wjg.v24.i22.2373</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Новиков В.В., Лапин В.А., Мелентьев Д.А., Мохонова Е.В. Особенности иммунного ответа человека на инфицирование Helicobacter pylori. МедиАль. 2019;(2):55–69. doi: 10.21145/2225-00262019-2-55-69</mixed-citation><mixed-citation xml:lang="en">Novikov V.V., Lapin V.A., Melent’ev D.A., Mokhonova E.V. Features of the human immune response to Helicobacter pylori infection. MediAl = MediAl. 2019;(2):55–69. [In Russian]. doi:10.21145/2225-0026-2019-2-55-69</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Jackson S., Beck P.L., Pineo G.F., Poon M.C. Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am. J. Hematol. 2005;78(2):142–150. doi: 10.1002/ajh.20250</mixed-citation><mixed-citation xml:lang="en">Jackson S., Beck P.L., Pineo G.F., Poon M.C. Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am. J. Hematol. 2005;78(2):142–150. doi: 10.1002/ajh.20250</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Asahi M., Azuma T., Ito S., Ito Y., Suto H., Nagai Y., Tsubokawa M., Tohyama Y., Maeda S., Omata M., Suzuki T., Sasakawa C. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. Med. 2000;191:593–602. doi: 10.1084/ jem.191.4.593</mixed-citation><mixed-citation xml:lang="en">Asahi M., Azuma T., Ito S., Ito Y., Suto H., Nagai Y., Tsubokawa M., Tohyama Y., Maeda S., Omata M., Suzuki T., Sasakawa C. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J. Exp. Med. 2000;191:593–602. doi: 10.1084/ jem.191.4.593</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Tummuru M.K., Sharma S.A., Blaser M.J. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol. 1995;18:867– 876. doi: 10.1111/j.1365-2958.1995.18050867.x</mixed-citation><mixed-citation xml:lang="en">Tummuru M.K., Sharma S.A., Blaser M.J. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol. Microbiol. 1995;18:867– 876. doi: 10.1111/j.1365-2958.1995.18050867.x</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Negovan A., Iancu M., Fülöp E., Bănescu C. Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions. World J. Gastroenterol. 2019;25(30):4105–4124. doi: 10.3748/wjg. v25.i30.4105</mixed-citation><mixed-citation xml:lang="en">Negovan A., Iancu M., Fülöp E., Bănescu C. Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions. World J. Gastroenterol. 2019;25(30):4105–4124. doi: 10.3748/wjg. v25.i30.4105</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Mendoza E., Duque X., Franco J.I.F., Maldonado E.R., Morán S., Martínez G., Rodríguez A.R., Martínez H. Association between active H. pylori infection and iron deficiency assessed by serum hepcidin levels in school-age children. Nutrients. 2019;11:2141. doi:10.3390/nu11092141</mixed-citation><mixed-citation xml:lang="en">Mendoza E., Duque X., Franco J.I.F., Maldonado E.R., Morán S., Martínez G., Rodríguez A.R., Martínez H. Association between active H. pylori infection and iron deficiency assessed by serum hepcidin levels in school-age children. Nutrients. 2019;11:2141. doi:10.3390/nu11092141</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">O’Connor H.J., Axon A.T., Dixon M.F. Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet. 1984;2:1091. doi: 10.1016/ s0140-6736(84)91523-x</mixed-citation><mixed-citation xml:lang="en">O’Connor H.J., Axon A.T., Dixon M.F. Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet. 1984;2:1091. doi: 10.1016/ s0140-6736(84)91523-x</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Saito M., Mori A., Irie T., Tanaka M., Morioka M. Helicobacter pylori infection is not associated with pernicious anemia in Japan. Rinsho Ketsueki. 2008;49(11):1569–1571. [In Japanese].</mixed-citation><mixed-citation xml:lang="en">Saito M., Mori A., Irie T., Tanaka M., Morioka M. Helicobacter pylori infection is not associated with pernicious anemia in Japan. Rinsho Ketsueki. 2008;49(11):1569–1571. [In Japanese].</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Kokkola A., Kosunen T.U., Puolakkainen P., Sipponen P., Harkonen M., Laxen F., Virtamo J., Haapiainen R., Rautelin H. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS Journal of Pathology, Microbiology and Immulogy. 2003;111:619– 624. doi: 10.1034/j.1600-0463.2003.1110604.x</mixed-citation><mixed-citation xml:lang="en">Kokkola A., Kosunen T.U., Puolakkainen P., Sipponen P., Harkonen M., Laxen F., Virtamo J., Haapiainen R., Rautelin H. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS Journal of Pathology, Microbiology and Immulogy. 2003;111:619– 624. doi: 10.1034/j.1600-0463.2003.1110604.x</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez A.M., Urrea D.A., Prada C.F. Helicobacter pylori virulence factors: relationship between genetic variability and phylogeographic origin. PeerJ. 2021;9:e12272. doi: 10.7717/peerj.12272</mixed-citation><mixed-citation xml:lang="en">Rodriguez A.M., Urrea D.A., Prada C.F. Helicobacter pylori virulence factors: relationship between genetic variability and phylogeographic origin. PeerJ. 2021;9:e12272. doi: 10.7717/peerj.12272</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Buerkli S., Ndiaye N.F., Cercamondi C.I., Herter-Aeberli I., Moretti D., Zimmermann M.B. Asymptomatic Helicobacter pylori infection in preschool children and young women does not predict iron bioavailability from iron-fortified foods. Nutrients. 2019;11:2093. doi:10.3390/nu11092093</mixed-citation><mixed-citation xml:lang="en">Buerkli S., Ndiaye N.F., Cercamondi C.I., Herter-Aeberli I., Moretti D., Zimmermann M.B. Asymptomatic Helicobacter pylori infection in preschool children and young women does not predict iron bioavailability from iron-fortified foods. Nutrients. 2019;11:2093. doi:10.3390/nu11092093</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Youssefi M., Tafaghodi M., Farsiani H., Ghazvini K., Keikha M. Helicobacter pylori infection and autoimmune diseases. Is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy gastritis and autoimmune pancreatitis? A systematic review and meta-analysis study. J. Microbiol. Immunol. Infect. 2021;54(3):359–369. doi: 10.1016/j. jmii.2020.08.011</mixed-citation><mixed-citation xml:lang="en">Youssefi M., Tafaghodi M., Farsiani H., Ghazvini K., Keikha M. Helicobacter pylori infection and autoimmune diseases. Is there an association with systemic lupus erythematosus, rheumatoid arthritis, autoimmune atrophy gastritis and autoimmune pancreatitis? A systematic review and meta-analysis study. J. Microbiol. Immunol. Infect. 2021;54(3):359–369. doi: 10.1016/j. jmii.2020.08.011</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Lenti M.V., Rugge M., Lahner E., Miceli E., Toh B.-H., Genta R.M., de Block C., Hershko C., di Sabatino F. Autoimmune gastritis. Nature Reviews Disease Primers. 2020;6(1):56. doi: 10.1038/ s41572-0200187-8</mixed-citation><mixed-citation xml:lang="en">Lenti M.V., Rugge M., Lahner E., Miceli E., Toh B.-H., Genta R.M., de Block C., Hershko C., di Sabatino F. Autoimmune gastritis. Nature Reviews Disease Primers. 2020;6(1):56. doi: 10.1038/ s41572-0200187-8</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Johnson K.S., Ottemann K.M. Colonization, localization, and inflammation: the roles of H. pylori chemotaxis in vivo. Curr. Opin. Microbiol. 2018;41:51– 57. doi:10.1016/j.mib.2017.11.019</mixed-citation><mixed-citation xml:lang="en">Johnson K.S., Ottemann K.M. Colonization, localization, and inflammation: the roles of H. pylori chemotaxis in vivo. Curr. Opin. Microbiol. 2018;41:51– 57. doi:10.1016/j.mib.2017.11.019</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Sung J.J.Y., Coker O.O., Chu E., Szeto C.H., Luk S. T., Lau H.C.H., Yu J. Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication. Gut. 2020; 69:1572–1581. doi:10.1136/gutjnl-2019-319826</mixed-citation><mixed-citation xml:lang="en">Sung J.J.Y., Coker O.O., Chu E., Szeto C.H., Luk S. T., Lau H.C.H., Yu J. Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication. Gut. 2020; 69:1572–1581. doi:10.1136/gutjnl-2019-319826</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Колмогорова Т.О., Анчикова Т.А. Роль Нelicobacter pylori в развитии синдрома избыточного бактериального роста. Доказат. гастроэнтерол. 2019;8(3):12–18. doi:10.17116/dokgastro2019803112</mixed-citation><mixed-citation xml:lang="en">Kolmogorova T.O., Anchikova T.A. The role of Нelicobacter pylori in the development of small intestinal bacterial overgrowth syndrome. Dokazatel’naya gastroenterologiya = Russian Journal of Evidence-Based Gastroenterology. 2019;8(3):12–18. [In Russian]. doi:10.17116/dokgastro2019803112</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Ливзан М.А., Гаус О.В., Мозговой С.И. Хронический атрофический гастрит: тактика курации пациента. РМЖ. Мед. обоз. 2021;5(6):427– 432. doi: 10.32364/2587-6821-2021-5-6-427-432</mixed-citation><mixed-citation xml:lang="en">Livzan M.A., Gaus O.V., Mozgovoy S.I. Chronic atrophic gastritis: patient management. RMJ. Meditsinskoe obozrenie = Russian Medical Inquiry. Medical Review 2021;5(6):427–432. [In Russian]. doi:10.32364/2587-6821-2021-5-6-427-432</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Crafa P., Russo M., Miraglia C., Barchi A., Moccia F., Nouvenne A., Leandro G., Meschi T., De’Angelis G.L., Di Mario F. From Sidney to OLGA: an overview of atrophic gastritis. Acta Biomed. 2018;89(8):93–99. doi: 10.23750/abm.v89i8-S.7946</mixed-citation><mixed-citation xml:lang="en">Crafa P., Russo M., Miraglia C., Barchi A., Moccia F., Nouvenne A., Leandro G., Meschi T., De’Angelis G.L., Di Mario F. From Sidney to OLGA: an overview of atrophic gastritis. Acta Biomed. 2018;89(8):93–99. doi: 10.23750/abm.v89i8-S.7946</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Lahner E., Marzinotto I., Lampasona V., Dottori L., Bazzigaluppi E., Brigatti C., Secchi M., Piemonti L., Conti L., Pilozzi E., … Annibale B. Autoantibodies toward ATP4A and ATP4B subunits of gastric proton pump H1,K1-ATPase are reliable serological pre-endoscopic markers of corpus atrophic gastritis. Clinical and Translational Gastroenterology. 2020;11(10):e00240. doi: 10.14309/ctg.0000000000000240</mixed-citation><mixed-citation xml:lang="en">Lahner E., Marzinotto I., Lampasona V., Dottori L., Bazzigaluppi E., Brigatti C., Secchi M., Piemonti L., Conti L., Pilozzi E., … Annibale B. Autoantibodies toward ATP4A and ATP4B subunits of gastric proton pump H1,K1-ATPase are reliable serological pre-endoscopic markers of corpus atrophic gastritis. Clinical and Translational Gastroenterology. 2020;11(10):e00240. doi: 10.14309/ctg.0000000000000240</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Rustgi S.D., Bijlani P., Shah S.C. Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management. Ther. Adv. Gastroenterol. 2021;14:17562848211038771. doi: 10.1177/17562848211038771</mixed-citation><mixed-citation xml:lang="en">Rustgi S.D., Bijlani P., Shah S.C. Autoimmune gastritis, with or without pernicious anemia: epidemiology, risk factors, and clinical management. Ther. Adv. Gastroenterol. 2021;14:17562848211038771. doi: 10.1177/17562848211038771</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Franceschi F., Annalisa T., Teresa D.T., Giovanna A., Ianiro G., Franco S., Viviana G., Valentina T., Riccardo L.L., Antonio G. Role of Helicobacter pylori infection on nutrition and metabolism. World J. Gastroenterol. 2014;20(36):12809–12817. doi: 10.3748/wjg. v20.i36.12809</mixed-citation><mixed-citation xml:lang="en">Franceschi F., Annalisa T., Teresa D.T., Giovanna A., Ianiro G., Franco S., Viviana G., Valentina T., Riccardo L.L., Antonio G. Role of Helicobacter pylori infection on nutrition and metabolism. World J. Gastroenterol. 2014;20(36):12809–12817. doi: 10.3748/wjg. v20.i36.12809</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Цуканов В.В., Тонких Ю.Л., Васютин А.В., Перетятько О.В., Пуликов А.С., Барон И.И. Структура слизистой оболочки желудка у пациентов с различными концентрациями и соотношениями пепсиногенов в сыворотке крови. Мед. сов. 2018;(14):114–117. doi:10.21518/2079701X-2018-14-114-117</mixed-citation><mixed-citation xml:lang="en">Tsukanov V.V., Tonkikh Ju.L., Vasyutin A.V., Peretyatko O.V., Pulikov A.S., Baron I.I. astric mucosa structure in patients with different serum pepsinogen levels and ratios. Meditsinskiy sovet = Medical Council. 2018;(14):114–117. [In Russian]. doi:10.21518/2079-701X-2018-14-114-117</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Vannella L., Lahner E., Osborn J., Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment. Pharmacol. Ther. 2013;37:375–382. doi: 10.1111/apt.12177</mixed-citation><mixed-citation xml:lang="en">Vannella L., Lahner E., Osborn J., Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment. Pharmacol. Ther. 2013;37:375–382. doi: 10.1111/apt.12177</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Lahner E., Persechino S., Annibale B. Micronutrients (Other than iron) and Helicobacter pylori infection: a systematic review. Helicobacter. 2012;17:1–15. doi: 10.1111/j.1523-5378.2011.00892.x</mixed-citation><mixed-citation xml:lang="en">Lahner E., Persechino S., Annibale B. Micronutrients (Other than iron) and Helicobacter pylori infection: a systematic review. Helicobacter. 2012;17:1–15. doi: 10.1111/j.1523-5378.2011.00892.x</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Маев И.В., Андреев Д.Н., Кучерявый Ю.А. Инфекция Helicobacter pylori и экстрагастродуоденальные заболевания. Терапевт. арх. 2015;87(8):103–110. doi:10.17116/terarkh2015878103-110</mixed-citation><mixed-citation xml:lang="en">Maev I.V., Andreev D.N., Kucheryavyi Ju.A. Helicobacter pylori infection and extragastroduodenal diseases. Terapevticheskiy arkhiv = Therapeutic Archive. 2015;87(8):103–110. [In Russian]. doi:10.17116 /terarkh 2015878103-110</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Асатуров А.В., Варзин С.А., Строев Ю.И., Чурилов Л.П., Утехин В.И. Роль аутоиммунологической реактивности в патогенезе осложненных форм язвенной болезни у детей и взрослых. Педиатр. 2018;9(6):93–100. doi:10.17816/ PED9693-100</mixed-citation><mixed-citation xml:lang="en">Asaturov A.V., Varzin S.A., Stroev Yu.I., Churilov L.P., Utekhin V.I. The role of autoimmune reactivity in pathogenesis of complicated forms of peptic ulcer disease in adults and children. Pediatr = Pediatrician. 2018;9(6):93–100. [In Russian]. doi:10.17816/PED9693-100</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Terrell D.R., Beebe L.A., Neas B.R., Vesely S.K., Segal J.B., George J.N. Prevalence of primary immune thrombocytopenia in Oklahoma. Am. J. Hematol. 2012;87:848–852. doi: 10.1002/ajh.23262</mixed-citation><mixed-citation xml:lang="en">Terrell D.R., Beebe L.A., Neas B.R., Vesely S.K., Segal J.B., George J.N. Prevalence of primary immune thrombocytopenia in Oklahoma. Am. J. Hematol. 2012;87:848–852. doi: 10.1002/ajh.23262</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Psaila B., Bussel J.B. Immune thrombocytopenic purpura. Hematol. Oncol. Clin. North. Am. 2007;21:743–759. doi: 10.1016/j.hoc.2007.06.007</mixed-citation><mixed-citation xml:lang="en">Psaila B., Bussel J.B. Immune thrombocytopenic purpura. Hematol. Oncol. Clin. North. Am. 2007;21:743–759. doi: 10.1016/j.hoc.2007.06.007</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Jang J.H., Kim J.Y., Mun Y.C., Bang S.M., Lim Y.J., Shin D.Y., Choi Y.B., Yhim H.Y., Lee J.W., Kook H., on the behalf of Korean Aplastic Anemia Working Party. Management of immune thrombocytopenia: Korean experts recommendation in 2017. Blood Res. 2017;52:254–263. doi: 10.5045/br.2017.52.4.254</mixed-citation><mixed-citation xml:lang="en">Jang J.H., Kim J.Y., Mun Y.C., Bang S.M., Lim Y.J., Shin D.Y., Choi Y.B., Yhim H.Y., Lee J.W., Kook H., on the behalf of Korean Aplastic Anemia Working Party. Management of immune thrombocytopenia: Korean experts recommendation in 2017. Blood Res. 2017;52:254–263. doi: 10.5045/br.2017.52.4.254</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">Fan H., Zhu H.L., Li S.X., Lu X.C., Zhai B., Guo B., Yao S.Q., Liu Y. Efficacy of amifostine in treating patients with idiopathic thrombocytopenia purpura. Cell Biochem. Biophys. 2011;59:7–12. doi:10.1007/ s12013-010-9100-5</mixed-citation><mixed-citation xml:lang="en">Fan H., Zhu H.L., Li S.X., Lu X.C., Zhai B., Guo B., Yao S.Q., Liu Y. Efficacy of amifostine in treating patients with idiopathic thrombocytopenia purpura. Cell Biochem. Biophys. 2011;59:7–12. doi:10.1007/ s12013-010-9100-5</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">Zain M.A., Zafar F., Ashfaq A., Jamil A.R., Ahmad A. Helicobacter pylori: An underrated Cause of immune thrombocytopenic purpura. A comprehensive review. Cureus. 2019;11(9):e5551. doi:10.7759/ cureus.5551</mixed-citation><mixed-citation xml:lang="en">Zain M.A., Zafar F., Ashfaq A., Jamil A.R., Ahmad A. Helicobacter pylori: An underrated Cause of immune thrombocytopenic purpura. A comprehensive review. Cureus. 2019;11(9):e5551. doi:10.7759/ cureus.5551</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Pezeshki S., Saki N., Ghandali M.V., Ekrami A., Avarvand A.Y. Effect of Helicobacter Pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East. Blood Res. 2021;56:38–43. doi: 10.5045/br.2021.2020189</mixed-citation><mixed-citation xml:lang="en">Pezeshki S., Saki N., Ghandali M.V., Ekrami A., Avarvand A.Y. Effect of Helicobacter Pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East. Blood Res. 2021;56:38–43. doi: 10.5045/br.2021.2020189</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">Hwang J.J., Lee D.H., Yoon H., Shin C.M., Park Y.S., Kim N. The effects of Helicobacter pylori eradication therapy for chronic idiopathic thrombocytopenic purpura. Gut Liver. 2016;10(3):356–361. doi: 10.5009/gnl14483</mixed-citation><mixed-citation xml:lang="en">Hwang J.J., Lee D.H., Yoon H., Shin C.M., Park Y.S., Kim N. The effects of Helicobacter pylori eradication therapy for chronic idiopathic thrombocytopenic purpura. Gut Liver. 2016;10(3):356–361. doi: 10.5009/gnl14483</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Franchini M., Veneri D. Helicobacter pylori-associated immune thrombocytopenia. Platelets. 2006;17:71–77. doi: 10.1080/09537100500438057</mixed-citation><mixed-citation xml:lang="en">Franchini M., Veneri D. Helicobacter pylori-associated immune thrombocytopenia. Platelets. 2006;17:71–77. doi: 10.1080/09537100500438057</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Gasbarrini A., Franceschi F., Tartaglione R., Landolfi R., Pola P., Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet. 1998;352:878. doi: 10.1016/ S0140-6736(05)60004-9</mixed-citation><mixed-citation xml:lang="en">Gasbarrini A., Franceschi F., Tartaglione R., Landolfi R., Pola P., Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet. 1998;352:878. doi: 10.1016/ S0140-6736(05)60004-9</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Noonavath R.N., Lakshmi Ch.P., Dutta T.K., Kate V. Helicobacter pylori eradication in patients with chronic immune thrombocytopenic purpura. World J. Gastroenterol. 2014;20(22):6918–6923. doi:10.3748/ wjg.v20.i22.6918</mixed-citation><mixed-citation xml:lang="en">Noonavath R.N., Lakshmi Ch.P., Dutta T.K., Kate V. Helicobacter pylori eradication in patients with chronic immune thrombocytopenic purpura. World J. Gastroenterol. 2014;20(22):6918–6923. doi:10.3748/ wjg.v20.i22.6918</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">Aljarad S., Alhamid A., Tarabishi A.S., Tarabishi A.S. # 2, Suliman A., Aljarad Z. The impact of Helicobacter pylori eradication on platelet counts of adult patients with idiopathic thrombocytopenic purpura. BMC Hematol. 2018;18:28. doi: 10.1186/s12878-0180119-y</mixed-citation><mixed-citation xml:lang="en">Aljarad S., Alhamid A., Tarabishi A.S., Tarabishi A.S. # 2, Suliman A., Aljarad Z. The impact of Helicobacter pylori eradication on platelet counts of adult patients with idiopathic thrombocytopenic purpura. BMC Hematol. 2018;18:28. doi: 10.1186/s12878-0180119-y</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Sheema K., Ikramdin U., Arshi N., Farah N., Imran S. Role of Helicobacter pylori eradication therapy on platelet recovery in chronic immune thrombocytopenic purpura. Gastroenterol. Res. Pract. 2017;2017:9529752. doi: 10.1155/2017/9529752</mixed-citation><mixed-citation xml:lang="en">Sheema K., Ikramdin U., Arshi N., Farah N., Imran S. Role of Helicobacter pylori eradication therapy on platelet recovery in chronic immune thrombocytopenic purpura. Gastroenterol. Res. Pract. 2017;2017:9529752. doi: 10.1155/2017/9529752</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">Jackson S., Beck P.L., Pineo G.F., Poon M.C. Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am. J. Hematol. 2005;78:142–150. doi: 10.1002/ ajh.20250</mixed-citation><mixed-citation xml:lang="en">Jackson S., Beck P.L., Pineo G.F., Poon M.C. Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature. Am. J. Hematol. 2005;78:142–150. doi: 10.1002/ ajh.20250</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Bettaieb A., Fromont P., Louache F., Oksenhendler E., Vainchenker W., Duédari N., Bierling P. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood. 1992;80(1):162–169.</mixed-citation><mixed-citation xml:lang="en">Bettaieb A., Fromont P., Louache F., Oksenhendler E., Vainchenker W., Duédari N., Bierling P. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood. 1992;80(1):162–169.</mixed-citation></citation-alternatives></ref><ref id="cit102"><label>102</label><citation-alternatives><mixed-citation xml:lang="ru">Bettaieb A., Oksenhendler E., Duedari N., Bierling P. Cross-reactive antibodies between HIVgp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura. Clin. Exp. Immunol. 1996;103(1):19–23. doi: 10.1046/j.13652249.1996.917606.x</mixed-citation><mixed-citation xml:lang="en">Bettaieb A., Oksenhendler E., Duedari N., Bierling P. Cross-reactive antibodies between HIVgp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura. Clin. Exp. Immunol. 1996;103(1):19–23. doi: 10.1046/j.13652249.1996.917606.x</mixed-citation></citation-alternatives></ref><ref id="cit103"><label>103</label><citation-alternatives><mixed-citation xml:lang="ru">Kim B.J, Kim H.S., Jang H.J., Kim J.H. Helicobacter pylori eradication in idiopathic thrombocytopenic purpura: a meta-analysis of randomized trials. Gastroenterology Research and Practice. 2018;2018:6090878. doi: 10.1155/2018/6090878</mixed-citation><mixed-citation xml:lang="en">Kim B.J, Kim H.S., Jang H.J., Kim J.H. Helicobacter pylori eradication in idiopathic thrombocytopenic purpura: a meta-analysis of randomized trials. Gastroenterology Research and Practice. 2018;2018:6090878. doi: 10.1155/2018/6090878</mixed-citation></citation-alternatives></ref><ref id="cit104"><label>104</label><citation-alternatives><mixed-citation xml:lang="ru">Asahi A., Nishimoto T., Okazaki Y., Suzuki H., Masaoka T., Kawakami Y., Ikeda Y., Kuwana M. Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J. Clin. Invest. 2008;118(8):2939–2949. doi: 10.1172/JCI34496</mixed-citation><mixed-citation xml:lang="en">Asahi A., Nishimoto T., Okazaki Y., Suzuki H., Masaoka T., Kawakami Y., Ikeda Y., Kuwana M. Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J. Clin. Invest. 2008;118(8):2939–2949. doi: 10.1172/JCI34496</mixed-citation></citation-alternatives></ref><ref id="cit105"><label>105</label><citation-alternatives><mixed-citation xml:lang="ru">Yamanishi S., Iizumi T., Watanabe E., Shimizu M., Kamiya S., Nagata K., Kumagai Y., Fukunaga Y., Takahashi H. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect. Immun. 2006;74(1):248–256. doi: 10.1128/IAI.74.1.248-256.2006</mixed-citation><mixed-citation xml:lang="en">Yamanishi S., Iizumi T., Watanabe E., Shimizu M., Kamiya S., Nagata K., Kumagai Y., Fukunaga Y., Takahashi H. Implications for induction of autoimmunity via activation of B-1 cells by Helicobacter pylori urease. Infect. Immun. 2006;74(1):248–256. doi: 10.1128/IAI.74.1.248-256.2006</mixed-citation></citation-alternatives></ref><ref id="cit106"><label>106</label><citation-alternatives><mixed-citation xml:lang="ru">Rahman Y.A., Wahid Ahmed L.A., Hafez R.M., Ahmed R.M.M. Helicobacter pylori and its hematological effect. The Egyptian Journal of Internal Medicine. 2019;31:332–342. doi: 10.4103/ejim.ejim_103_18</mixed-citation><mixed-citation xml:lang="en">Rahman Y.A., Wahid Ahmed L.A., Hafez R.M., Ahmed R.M.M. Helicobacter pylori and its hematological effect. The Egyptian Journal of Internal Medicine. 2019;31:332–342. doi: 10.4103/ejim.ejim_103_18</mixed-citation></citation-alternatives></ref><ref id="cit107"><label>107</label><citation-alternatives><mixed-citation xml:lang="ru">Byrne M.F., Kerrigan S.W., Corcoran P.A., Atherton J.C., Murray F.E., Fitzgerald D.J., Cox D.M. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology. 2003;124(7):1846–1854. doi: 10.1016/ s0016-5085(03)00397-4</mixed-citation><mixed-citation xml:lang="en">Byrne M.F., Kerrigan S.W., Corcoran P.A., Atherton J.C., Murray F.E., Fitzgerald D.J., Cox D.M. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology. 2003;124(7):1846–1854. doi: 10.1016/ s0016-5085(03)00397-4</mixed-citation></citation-alternatives></ref><ref id="cit108"><label>108</label><citation-alternatives><mixed-citation xml:lang="ru">Scopel-Guerra A., Olivera-Severo D., Staniscuaski F., Uberti A.F., Callai-Silva N., Jaeger N., Porto B.N., Carlini C.R. The impact of Helicobacter pylori urease upon platelets and consequent contributions to inflammation. Front. Microbiol. 2017;8:2447. doi: 10.3389/fmicb.2017.02447</mixed-citation><mixed-citation xml:lang="en">Scopel-Guerra A., Olivera-Severo D., Staniscuaski F., Uberti A.F., Callai-Silva N., Jaeger N., Porto B.N., Carlini C.R. The impact of Helicobacter pylori urease upon platelets and consequent contributions to inflammation. Front. Microbiol. 2017;8:2447. doi: 10.3389/fmicb.2017.02447</mixed-citation></citation-alternatives></ref><ref id="cit109"><label>109</label><citation-alternatives><mixed-citation xml:lang="ru">Appelmelk B.J., van Die I., van Vliet S.J., Vandenbroucke-Grauls C.M., Geijtenbeek T.B., van Kooyk Y. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 2003;170(4):1635–1639. doi: 10.4049/jimmunol.170.4.1635</mixed-citation><mixed-citation xml:lang="en">Appelmelk B.J., van Die I., van Vliet S.J., Vandenbroucke-Grauls C.M., Geijtenbeek T.B., van Kooyk Y. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J. Immunol. 2003;170(4):1635–1639. doi: 10.4049/jimmunol.170.4.1635</mixed-citation></citation-alternatives></ref><ref id="cit110"><label>110</label><citation-alternatives><mixed-citation xml:lang="ru">Voland P., Hafsi N., Zeitner M., Laforsch S., Wagner H., Prinz C. Antigenic properties of HpaA and Omp18, two outer membrane proteins of Helicobacter pylori. Infect. Immun. 2003;71(7):3837–3843. doi:10.1128/IAI.71.7.3837-3843.2003</mixed-citation><mixed-citation xml:lang="en">Voland P., Hafsi N., Zeitner M., Laforsch S., Wagner H., Prinz C. Antigenic properties of HpaA and Omp18, two outer membrane proteins of Helicobacter pylori. Infect. Immun. 2003;71(7):3837–3843. doi:10.1128/IAI.71.7.3837-3843.2003</mixed-citation></citation-alternatives></ref><ref id="cit111"><label>111</label><citation-alternatives><mixed-citation xml:lang="ru">Holland R.L., Bosi K.D., Harpring G.H., Luo J., Wallig M., Phillips H., Blanke S.R. Chronic in vivo exposure to Helicobacter pylori VacA: Assessing the efficacy of automated and long-term intragastric toxin infusion. Sci. Rep. 2020;10:9307. doi: 10.1038/ s41598-020-65787-3</mixed-citation><mixed-citation xml:lang="en">Holland R.L., Bosi K.D., Harpring G.H., Luo J., Wallig M., Phillips H., Blanke S.R. Chronic in vivo exposure to Helicobacter pylori VacA: Assessing the efficacy of automated and long-term intragastric toxin infusion. Sci. Rep. 2020;10:9307. doi: 10.1038/ s41598-020-65787-3</mixed-citation></citation-alternatives></ref><ref id="cit112"><label>112</label><citation-alternatives><mixed-citation xml:lang="ru">Satoh K., Hirayama T., Takano K., SuzukiInoue K., Sato T., Ohta M., Nakagomi J., Ozaki Y. VacA, the vacuolating cytotoxin of Helicobacter pylori, binds to multimerin 1 on human platelets. Thromb. J. 2013;11:23. doi: 10.1186/1477-9560-11-23</mixed-citation><mixed-citation xml:lang="en">Satoh K., Hirayama T., Takano K., SuzukiInoue K., Sato T., Ohta M., Nakagomi J., Ozaki Y. VacA, the vacuolating cytotoxin of Helicobacter pylori, binds to multimerin 1 on human platelets. Thromb. J. 2013;11:23. doi: 10.1186/1477-9560-11-23</mixed-citation></citation-alternatives></ref><ref id="cit113"><label>113</label><citation-alternatives><mixed-citation xml:lang="ru">Frydman G.H., Davis N., Beck P.L., Fox J.G. Helicobacter pylori eradication in patients with immune thrombocytopenic ourpura: a review and the role of biogeography. Helicobacter. 2015;20:239–251. doi: 10.1111/hel.12200</mixed-citation><mixed-citation xml:lang="en">Frydman G.H., Davis N., Beck P.L., Fox J.G. Helicobacter pylori eradication in patients with immune thrombocytopenic ourpura: a review and the role of biogeography. Helicobacter. 2015;20:239–251. doi: 10.1111/hel.12200</mixed-citation></citation-alternatives></ref><ref id="cit114"><label>114</label><citation-alternatives><mixed-citation xml:lang="ru">Veneri D., de Matteis G., Solero P., Federici F., Zanuso C., Guizzardi E., Arena S., Gaio M., Pontiero P., Ricetti M.M., Franchini M. Analysis of Band Tcell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment. Platelets. 2005;16:307–311. doi: 10.1080/09537100400028685</mixed-citation><mixed-citation xml:lang="en">Veneri D., de Matteis G., Solero P., Federici F., Zanuso C., Guizzardi E., Arena S., Gaio M., Pontiero P., Ricetti M.M., Franchini M. Analysis of Band Tcell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment. Platelets. 2005;16:307–311. doi: 10.1080/09537100400028685</mixed-citation></citation-alternatives></ref><ref id="cit115"><label>115</label><citation-alternatives><mixed-citation xml:lang="ru">Sugano K., Tack J., Kuipers E.J., Graham D.Y., El-Omar E.M., Miura S., Haruma K., Asaka M., Uemura N., Malfertheineret P., faculty members of Kyoto Global Consensus Conference. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015; 64:1353–1367. doi:10.1136/gutjnl-2015-309252</mixed-citation><mixed-citation xml:lang="en">Sugano K., Tack J., Kuipers E.J., Graham D.Y., El-Omar E.M., Miura S., Haruma K., Asaka M., Uemura N., Malfertheineret P., faculty members of Kyoto Global Consensus Conference. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015; 64:1353–1367. doi:10.1136/gutjnl-2015-309252</mixed-citation></citation-alternatives></ref><ref id="cit116"><label>116</label><citation-alternatives><mixed-citation xml:lang="ru">Neunert C., Terrell D.R., Arnold D.M., Buchanan G., Cines D.B., Cooper N., Cuker A., Despotovic J.M., George J.N., Grace R.F., … Vesely S.K. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3:3829– 3866. doi: 10.1182/bloodadvances.2019000966</mixed-citation><mixed-citation xml:lang="en">Neunert C., Terrell D.R., Arnold D.M., Buchanan G., Cines D.B., Cooper N., Cuker A., Despotovic J.M., George J.N., Grace R.F., … Vesely S.K. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019;3:3829– 3866. doi: 10.1182/bloodadvances.2019000966</mixed-citation></citation-alternatives></ref><ref id="cit117"><label>117</label><citation-alternatives><mixed-citation xml:lang="ru">Fock K.M., Katelaris P., Sugano K., Ang T.L., Hunt R., Talley N.J., Lam S.K., Xiao S.D., Tan H.J., Wu C.Y., … Second Asia-Pacific Conference. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J. Gastroenterol. Hepatol. 2009;24:1587– 1600. doi: 10.1111/j.1440-1746.2009.05982.x</mixed-citation><mixed-citation xml:lang="en">Fock K.M., Katelaris P., Sugano K., Ang T.L., Hunt R., Talley N.J., Lam S.K., Xiao S.D., Tan H.J., Wu C.Y., … Second Asia-Pacific Conference. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J. Gastroenterol. Hepatol. 2009;24:1587– 1600. doi: 10.1111/j.1440-1746.2009.05982.x</mixed-citation></citation-alternatives></ref><ref id="cit118"><label>118</label><citation-alternatives><mixed-citation xml:lang="ru">Masataka K. Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms. World J. Gastroenterol. 2014;20(3):714–723. doi: 10.3748/wjg.v20.i3.714</mixed-citation><mixed-citation xml:lang="en">Masataka K. Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms. World J. Gastroenterol. 2014;20(3):714–723. doi: 10.3748/wjg.v20.i3.714</mixed-citation></citation-alternatives></ref><ref id="cit119"><label>119</label><citation-alternatives><mixed-citation xml:lang="ru">Kuwana M. Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms. World J. Gastroenterol. 2014;20:714–723. doi: 10.3748/wjg.v20.i3.714</mixed-citation><mixed-citation xml:lang="en">Kuwana M. Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms. World J. Gastroenterol. 2014;20:714–723. doi: 10.3748/wjg.v20.i3.714</mixed-citation></citation-alternatives></ref><ref id="cit120"><label>120</label><citation-alternatives><mixed-citation xml:lang="ru">Национальное гематологическое общество, Национальное общество детских гематологов и онкологов. Клинические рекомендации. Железодефицитная анемия. Режим доступа: https://npngo.ru/uploads/media_document/636/161b822a-e1f64c71-a39b-975866e61ff8.docx</mixed-citation><mixed-citation xml:lang="en">National Society of Hematology, National Society of Pediatric Hematologists and Oncologists. Clinical guidelines. Iron-deficiency anemia. Available at: https://npngo.ru/uploads/media_document/636/161b822ae1f6-4c71-a39b-975866e61ff8.docx [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit121"><label>121</label><citation-alternatives><mixed-citation xml:lang="ru">Национальное гематологическое общество, Национальное общество детских гематологов, онкологов. Клинические рекомендации. ВитаминB12-дефицитная анемия. Режим доступа: https://npngo.ru/uploads/media_document/634/bb602760b006-4983-a56e-c3bc333b6151.docx</mixed-citation><mixed-citation xml:lang="en">National Hematological Society, National Society of Pediatric Hematologists, Oncologists. Clinical guidelines. Vitamin B12 deficiency anemia. Available at: https://npngo.ru/uploads/media_document/634/bb602760-b006-4983-a56e-c3bc333b6151.docx [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit122"><label>122</label><citation-alternatives><mixed-citation xml:lang="ru">Национальное гематологическое общество. Клинические рекомендации. Идиопатическая тромбоцитопеническая пурпура (ИТП) у взрослых. Режим доступа: https://npngo.ru/uploads/media_document/631/4a7a26c4-0f1b-4588-b2db-4b99d54d72e5. pdf</mixed-citation><mixed-citation xml:lang="en">National Hematological Society. Clinical guidelines. Idiopathic thrombocytopenic purpura (ITP) in adults. Available at: https://npngo.ru/uploads/media_document/631/4a7a26c4-0f1b-4588-b2db-4b99d54d72e5.pdf [In Russian].</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
